Editors’ Picks: Highlights From the AACR Journals
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
In an innovative new initiative to drive progress against cancer, the American Association for Cancer Research (AACR) has announced...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...
Grab a cold drink and escape the midsummer heat with July’s rendition of Editors’ Picks. This month, the editors...
Improved patient outcomes come from new treatments. New treatments stem from successful clinical trials. Clinical trials build on discoveries...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
As we head into summer, enjoy this month’s selection of studies spotlighted by the editors of the 10 AACR...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...